Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€9.75
07.04.24
€13.00
07.04.25
-17.28%
28.04.24

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.50
15.02.24
-
15.02.25
-3.09%
17.02.24

Risky Investment
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.20
24.12.23
-
24.12.24
1.36%
06.01.24

Could be worthwhile Investment >10% per year
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.40
24.10.23
-
24.10.24
-62.14%
28.10.23

Could be worthwhile Investment >10% per year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.23
17.09.23
-
17.09.24
-11.30%
02.10.23

Could be very worthwhile Investment >20% year
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.30
14.09.23
-
14.09.24
-1.50%
16.09.23

Probably not worthwhile Investment
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.85
03.09.23
-
03.09.24
-7.01%
16.09.23

Could be worthwhile Investment >10% per year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.98
21.08.23
-
21.08.24
-1.45%
02.09.23

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.08
07.08.23
-
07.08.24
-1.10%
19.08.23

Risky Investment
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.03
08.07.23
-
08.07.24
-18.91%
26.11.23

Could be worthwhile Investment >10% per year
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.00
19.05.23
€2.20
19.05.24
-63.20%
01.10.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.95
06.05.23
-
06.05.24
-36.50%
07.05.24

Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.44
30.04.23
-
30.04.24
-70.95%
01.05.24

Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.43
30.04.23
-
30.04.24
-47.00%
01.05.24

Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.55
22.04.23
-
22.04.24
-76.33%
23.04.24

Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.41
22.04.23
-
22.04.24
-43.90%
23.04.24

BELLUS Health Inc.

Start price
Target price
Perf. (%)
€13.20
18.04.23
-
18.04.24
-1.52%
27.04.23

Growths slower than the competition
Higher risks for its business
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.80
03.04.23
-
03.04.27
-12.14%
11.03.24

Could be worthwhile Investment >10% per year
buy
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.46
29.03.23
€25.81
29.03.24
-22.36%
30.03.24

buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.87
24.03.23
-
24.03.24
12.58%
18.05.23

Could be very worthwhile Investment >20% year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.77
21.03.23
-
21.03.24
-7.32%
02.04.23

Could be very worthwhile Investment >20% year
buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.30
20.03.23
-
20.03.24
6.18%
23.03.23

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.52
19.03.23
-
19.03.24
-24.05%
20.03.24

buy
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€0.99
15.03.23
€15.12
15.03.24
-60.91%
16.03.24

AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.50
11.03.23
-
11.03.24
-31.76%
12.03.24